A virtual platform for healthcare professionals to share knowledge in oncology worldwide.
Watch Our SessionsShare Your Patient Case


Roundtable on Multiple Myeloma

Wednesday, 25 May 2022 • 5 PM (CEST) | 11 AM (EST)

Francesca Gay

Francesca Gay

University of Torino,

Maria-Victoria Mateos

Maria-Victoria Mateos

University Hospital Salamanca, Spain

Mohamad Mohty

Mohamad Mohty

Saint-Antoine Hospital, Sorbonne University, France

This Session Is Recorded And Available Now!

Current SoC in 1L Multiple Myeloma: Transplant-Eligible and Non-Transplant-Eligible patients
M-V. Mateos

Multiple Myeloma Not Refractory to Lenalidomide
F. Gay

Multiple Myeloma Refractory to Lenalidomide
M. Mohty

Discussion with viewer questions and patient cases

Oncology CME-certified Accreditation
Virtual Live Meeting:
2 CME Credits from Swiss Society of Hematology

Share this on Social Media!

Together with scientific leaders in hematology, we explored how to proceed within and beyond frontline therapies and what patients are suitable for which therapy regimen. This interactive discussion on available treatment options in multiple myeloma is recorded and available behind the login curtain. 

Register Here

Do You Have An Account Already?
No need to sign up again: as a verified OncoViewer, you will have access to all our upcoming sessions. Simply login to participate in this session.

First Time On OncoViews?

Get Registered Now

This session is kindly supported by our partners with no influence on the content

Janssen Logo
BMS Logo White


Targeted Therapies in NSCLC

hosted by Oliver Gautschi
Cantonal Hospital Lucerne, Switzerland

Targeted Therapies in NSCLC

Jarushka Naidoo
Beaumont Hospital Dublin,

Targeted Therapies in NSCLC

Martin Reck
Lungenclinic Großhansdorf, Germany

GI Cancers

hosted by Sara De Dosso
Oncology Institute of Southern Switzerland, Bellinzona

GI Cancers

Thibaud Kössler
University Hospital Geneva,

GI Cancers

Florian Lordick
University Cancer Center Leipzig, Germany

Breast Cancer

hosted by Matteo Lambertini
Ospedale Policlinico San Martino, University of Genova, Italy

Breast Cancer

Cristina Saura
Vall d’Hebron University Hospital, Barcelona, Spain

Breast Cancer

Khalil Zaman
Breast Center CHUV, Lausanne, Switzerland



Missed Any Session?

Watch Our Virtual Round-Tables Now On Demand!

We had great discussions on the latest in hematology and oncology, from WCLC, ASCO, ESMO & SABCS. All round-tables are recorded and available for you behind the login curtain. 



Lung Cancer

GU Cancers

Women’s Cancers

GI Cancers



Will I be able to re-access the live discussions?

Yes, absolutely. All our live sessions are recorded and made available within 24 hours on our portal so that you can play it on demand as often as you like.

Does it cost me anything?

 Access to all our sessions are free of charge for healthcare professionals, students, scientists or other staff from universities, hospitals & research labs as well as policy & non-profit organisations and sponsoring partners. Only registrations by non-sponsoring industry representatives are subject to a fee.

Why do you need my details for registration?

In accordance with Swiss and European regulations, we require some information about you for verification purposes to ensure that the content of our initiatives is aimed at healthcare professionals and those involved in the science, management and treatment of cancer. We will not share your personal details with any sponsor or any third party - promised!

How can I get involved in the discussion?
Please feel submit your questions or patient cases before or during our live webinars! With that you will be able to interact and influence the discussion. Submit your question or a patient case here.








Countdown until our next OncoViews session

Watch Our Virtual Round-Tables on Latest in Oncology

The virtual round-table and online content is only accessible to students of medicine and life sciences, certified healthcare professionals, associated press, industry representatives and other stakeholders in the science, management and prevention of cancer.